Georgi Apriamashvili

I started my PhD in Daniel’s group in October 2016.

By harnessing the power of functional genomic screening approaches, I am aiming to uncover novel tumor vulnerabilities to immunotherapy. At the same time I am aiming to better understand and enhance cytotoxic T cells functionality.